Danaher shares jump 7% as the turnaround in biotech spending finally arrives

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here.

Articles You May Like

The decision to sell your home vs. rent it out is ‘complicated,’ experts say — what to know
Analysts say Corona brewer is a buy despite slowdown in sales across the industry
Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings
IRS extends Free File tax program through 2029
Advertisers boost spending at retailers such as Walmart and Amazon as TV shrinks

Leave a Reply

Your email address will not be published. Required fields are marked *